BIOMAT Database Logo BIOMAT Database Logo

Amphotericin B in visceral leishmaniasis. 1993

O P Giri
Department of Medicine, Darbhanga Medical College.

UI MeSH Term Description Entries
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

O P Giri
Amphotericin B in visceral leishmaniasis.
November 1996, Indian pediatrics,
O P Giri
Amphotericin B in resistant visceral leishmaniasis.
June 1996, Indian pediatrics,
O P Giri
Amphotericin B for visceral leishmaniasis in hemodialysis.
January 1991, Nephron,
O P Giri
Amphotericin B lipid complex: in visceral leishmaniasis.
January 2004, Drugs,
O P Giri
Visceral leishmaniasis treated with liposomal amphotericin B.
January 1999, The Pediatric infectious disease journal,
O P Giri
Liposomal amphotericin B in drug-resistant visceral leishmaniasis.
May 1991, Lancet (London, England),
O P Giri
Visceral leishmaniasis following treatment with liposomal amphotericin B.
August 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
O P Giri
Different liposomal amphotericin B formulations for visceral leishmaniasis.
August 2014, The Lancet. Global health,
O P Giri
Single-dose liposomal amphotericin B for visceral leishmaniasis.
April 2014, The Lancet. Global health,
O P Giri
Visceral leishmaniasis in pregnancy - the role of amphotericin B.
April 2008, Annals of tropical medicine and parasitology,
Copied contents to your clipboard!